Scholars Central

Conference abstractPublished 25 Sep 2014

Molecular modeling design, synthesis and antihyperglycemic evaluation of certain 5-(arylalkoxybenzylidine)- imidazolidine-2,4-dione derivatives as potential PPARγ agonists

Authors: Michelyne Haroun, Christophe Tratrat

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A new series of substituted 5-(aryl-alkoxy-benzylidine)-Imidazolidine-2,4-dione derivatives (IVa-f, Va), were designed as selective PPARγ agonists analogous to the reference drug; rosiglitazone(1). The comparative Fit/Dock scores of IVa-f molecules with the PPARγ agonists? hypothesis and the 3D structure of PPARγ receptor were nearly similar to the reference drug (1); while the designed molecule (Va) have higher scores than 1. The designed molecules were synthesized and evaluated for their anti-hyperglycemic activity on hyperglycemic animal model, where compounds IVa-IVe showed similar or slightly higher anti-hyperglycemic activity in comparison to 1, whereas compounds IVf and Va gave the highest activity among the designed molecules by 1.2 and 1.3 higher anti-hyperglycemic activity than rosiglitazone.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Developing Drugs
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Michelyne Haroun”
  • BylineArticles whose byline prints “Christophe Tratrat”